ArticlePloS one2017

Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome.

Yang Jo Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.